- Research works
- 1 fractional, all time
- Citations
- 68 106.2 per fractional work
- Top-10% rate
- 23.1% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: AIM at Melanoma Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does AIM at Melanoma Foundation publish most on?
By volume in 2022–2025: Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Ocular Oncology and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Melanoma and MAPK Pathways Molecular Biology 0 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Ocular Oncology and Treatments Ophthalmology 0 works
- 5 Cutaneous Melanoma Detection and Management Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AIM at Melanoma Foundation's research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Plano
- Huawei Technologies (United States)
- Plano Cancer Institute
- Ericsson (United States)
- Texas Back Institute
- Heart Hospital Baylor Plano
- Collin College
- Plano Orthopedic Sports Medicine & Spine Center
- Estech Systems (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.